The S&P 500’s record highs in 2026 invite the same analytical error that most market records invite: the assumption that a high level and a healthy market are the same thing. They are not. A market can reach record levels on the back of multiple expansion in a narrow group of large-cap names, financial engineering through share buybacks, and investor willingness to pay more for earnings growth that the underlying economy is not broadly delivering. Understanding which of those forces is driving the current record — and in what proportion — matters enormously for portfolio positioning and risk management in a way that simply noting the market is at an all-time high does not.
The internal composition of the current equity rally shows a market that is strong at the top and considerably more complicated below the surface. The breakdown in bonds-equities correlation that has characterised 2025 and 2026 is one dimension of this complexity. The earnings quality, valuation dispersion, and market breadth picture is another, and it requires more disaggregation than index-level analysis provides.
The Narrow Rally Problem
The defining structural feature of US equity markets since 2023 has been the concentration of returns in a small number of mega-cap technology and AI-adjacent companies. Nvidia, Microsoft, Apple, Alphabet, Meta, and Amazon have collectively driven a disproportionate share of S&P 500 index returns, both because their market capitalisation weights are large and because their individual stock performance has outpaced the broader market by wide margins. The result is that a cap-weighted S&P 500 investment has performed significantly better than an equal-weighted investment in the same 500 companies.
This concentration is not unprecedented — the late 1990s technology concentration is the obvious precedent — but it creates an analytical complication for investors using the index level as a signal about broad market health. When the equal-weighted S&P 500 underperforms its cap-weighted counterpart by multiple percentage points over a sustained period, it indicates that the majority of companies in the index are delivering below-average returns while a small group drives the headline. The market is not broadly expensive or broadly cheap; it is expensive in some places and more reasonably valued in others, and the aggregate index obscures that distribution.
The practical implication for investors who benchmark to the S&P 500 is that the index’s record performance partly reflects index mechanics — the largest companies get larger weights as their prices rise, creating a self-reinforcing index construction effect — rather than purely the fundamental investment quality of the underlying companies. Recognising this does not require predicting a reversal, but it does require acknowledging that the current index level is not a uniformly strong endorsement of broad US corporate performance.
Earnings Quality: What the Numbers Actually Show
Corporate earnings in 2026 are growing, but the composition of that growth warrants scrutiny. Reported earnings per share growth has been supported by three mechanisms: genuine revenue growth in high-performing sectors, operating leverage as cost discipline from the 2022-2023 cycle persists, and financial engineering through share buybacks that reduce the denominator in earnings-per-share calculations without increasing total corporate earnings.
Share buybacks have been running at historically elevated levels among S&P 500 companies. The combination of corporate tax reform and strong free cash flow generation in technology and energy companies has supported buyback volumes that mechanically improve EPS growth independent of any improvement in underlying business performance. A company that grows operating income by 5 percent but reduces its share count by 4 percent through buybacks reports 9 percent EPS growth — a number that looks like business momentum but is partly financial leverage on existing performance.
This is not inherently problematic — buybacks represent legitimate capital allocation when companies lack better investment opportunities — but it means that investors paying elevated multiples on EPS should be aware that some portion of what they are paying for is financial engineering rather than organic earnings growth. The quality of earnings matters for valuing growth: revenue growth is more durable and more expandable than share count reduction, and the two should not be treated identically in a valuation framework.
Valuation: Where the Stretched Multiples Actually Are
The S&P 500’s forward price-to-earnings multiple in 2026 sits at levels that are elevated relative to the index’s own history, though the aggregate number masks extreme variation by sector. Technology and communication services — the mega-cap heavy sectors — trade at multiples that price in sustained high growth for an extended period. Industrials, energy, healthcare, and financials trade at considerably more modest multiples that reflect either slower expected growth or investor indifference born of years of underperformance relative to technology.
The interest rate environment shapes this valuation picture directly. Higher-for-longer rates create a headwind for long-duration growth assets — technology stocks whose value derives from cash flows far in the future — while being a relative tailwind for financials that benefit from net interest margin and for companies whose earnings are less rate-sensitive because they are shorter-duration in cash flow terms. The valuation dispersion between high-multiple growth stocks and low-multiple value sectors is partly a duration story, and the persistence of that dispersion depends significantly on the rate path.
For investors evaluating whether to add equity exposure at current levels: the relevant question is not whether the S&P 500 as an index is cheap or expensive in the abstract, but whether the specific sector and stock exposures they would be adding are reasonably priced given their expected earnings growth. Technology at 30-35x forward earnings is priced for continued AI-driven growth acceleration; energy at 10-12x forward earnings is priced for a much more cautious view of future demand. Those are separate investment decisions that happen to be aggregated into the same index.
Where Value Persists in the Current Market
The narrow-rally structure that has characterised recent US equity performance creates identifiable pockets of relative value in sectors that have underperformed the mega-cap technology trade. Financials — banks and insurance companies — have benefited from higher rates but trade at multiples that do not fully reflect their improved earnings power. Healthcare companies outside the GLP-1 weight loss drug segment trade at multiples that reflect ongoing regulatory uncertainty rather than fundamental business deterioration. Energy producers sit at cash flow yields that imply investor scepticism about long-term energy demand that may be miscalibrated.
None of these value opportunities represent slam-dunk investments — they carry the specific risks of their sectors, including credit cycle risk for financials, regulatory and pricing risk for healthcare, and the long-term energy transition for energy. But investors who have been systematically underweight these sectors in favour of technology concentration are carrying valuation risk that is less obvious from the index level than from sector-by-sector analysis.
The dollar weakness environment has also improved the relative attractiveness of international equities in dollar terms, creating a portfolio diversification case that is separate from the domestic sector rotation argument. European value stocks, Japanese financials, and selected EM equities have benefited from dollar depreciation and from multiple expansion off genuinely depressed starting valuations.
What the Q2 2026 Earnings Season Will Reveal
The practical near-term test for the US equity rally’s internal health is the Q2 2026 earnings season, where three signals will be particularly informative. First, the revenue growth rate at mega-cap technology companies: if AI-driven revenue acceleration is sustaining the valuations of Nvidia, Microsoft, and Alphabet, the evidence should appear in top-line growth figures rather than just margins and buyback-driven EPS. Second, the guidance language around capital expenditure: companies that are committing to sustained AI infrastructure investment are pricing in a growth environment that must eventually appear in revenue to justify the spending. Third, the earnings performance of the S&P 500 ex-technology: if the rest of the index is growing earnings in line with the mega-caps, the narrow rally thesis softens; if it continues to lag significantly, the breadth concern intensifies.
The current record market level is not a problem that requires immediate portfolio action. Markets can trade at elevated multiples for extended periods when investor confidence is high and alternatives are limited. But treating the record as evidence of uniform health rather than aggregated strength in a narrow segment misses the analytical work that determines whether current allocations are appropriately positioned for the range of outcomes that 2026 might deliver. The level tells you where the market is. The composition tells you why.
